The Pan-Cancer Screen: Still Early for Prime Time
Xconomy
JULY 18, 2016
I would be ecstatic to have a simple tool for my patients that could detect cancers like ovarian and pancreatic that currently have no effective screening approach. No surprise, then, that a host of companies are working on molecular diagnostics to detect early-stage cancers or pre-cancers using non-invasive methods.
Let's personalize your content